Volume 14 Issue 7, July 1996

“B” ark lands at BIO

Ripen-on-command: In a society with ample food, why bother?

• Margaret Mellon

Produce-on-demand: What's good for US markets is good for world markets too

• David Evans

Biosafety protocol draft spooks US biotechnology officials

• Russ Hoyle

Host-defense peptides

• Robert L. Erwin

Kenneth J. Kelley responds: Host-defense peptides

• Kenneth J. Kelley

Software on the Internet

• Steven Goldby

John Hodgson responds: Software on the Internet

• John Hodgson

Arabidopsis sequencing

• A. Cavalieri

Business and Regulatory News

Research News

Genset sets tone for global biotechnology financing

• Mike Ward

Myotrophin approved by a whisker

• Vicki Brower

Berlex continues legal challenge to FDA over MS drug

• Vicki Glaser

Approved or advanced experimental MS therapies

• Andrew Marshall

Mid-sized companies discover biotechnology deals

• Sylvia Davidson

Rifkin marshals feminists against gene patents

• Vicki Brower

Antisense companies reach reality

• John Hodgson

Codex pressured on biotechnology food labels

• Jeffrey L. Fox

Bioremediation companies engineer new consortia

• Emma Johnson

Is British Biotech's Marimastat a major cancer drug?

• Sylvia Davidson

Genetically engineered mosquitoes fight infection

• Vicki Glaser

Summertime, and the living is sneezy

• Barbara Nasto

Commercial collaborations do not encourage misconduct

• Andrew Marshall

It's not the size, it's the potency

• Tod Woolf

Generating high-avidity human Mabs in mice

• Michael Neuberger

Suicidal tumor proteases

• Bonnie F. Sloane

Databases for gene expression

• George M. Church

Silent genes and everlasting fruits and vegetables?

• Don Grierson

Immune system under assault in Massachusetts

• Scott W. Umlauf
• Una S. Ryan

Biotechnology and the UN: New challenges, new failures

• Henry I. Miller

Refining the telomere-telomerase hypothesis of aging and cancer

• Shawn E. Holt
• Jerry W. Shay
• Woodring E. Wright

Potent and selective inhibition of gene expression by an antisense heptanucleotide

• Richard W. Wagner
• Mark D. Matteucci
• Brian C. Froehler

High-avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic mice

• Dianne M. Fishwild
• Susan L. O'Donnell
• Nils Lonberg

Tumor protease-activated, pore-forming toxins from a combinatorial library

• Rekha G. Panchal
• Evelyn Cusack
• Hagan Bayley

Selective amplification of protein-coding regions of large sets of genes using statistically designed primer sets

• Carlos E. López-Nieto
• Sanjay K. Nigam

Expression of ACC oxidase antisense gene inhibits ripening of cantaloupe melon fruits

• Ricardo Ayub
• Monique Guis
• Jean-Claude Pech

High-level expression of recombinant human fibrinogen in the milk of transgenic mice

• Donna Prunkard
• Ian Cottingham
• Donald Foster

In vitro hydrogen production by glucose dehydrogenase and hydrogenase

• Jonathan Woodward
• Susan M. Mattingly
• Michael Adams

Expression of a novel high-molecular-weight glutenin subunit gene in transgenic wheat

• Ann E. Blechl
• Olin D. Anderson

Use of microphysiometry for analysis of heterologous ion channels expressed in yeast

• Karen M. Hahnenberger
• Mark Krystal
• Stephen Kurtz

FACS-based isolation of slowly growing cells: Double encapsulation of yeast in gel microdrops

• Elizabeth A. Gift
• Hyun J. Park
• James C. Weaver

What Markman should mean to you

• Eugene C. Rzucidlo
• Dorothy R. Auth

Doppelgänger proteins as drug leads

• Barry Robson

Zurich hazard analysis in biotechnology

• Bernhard Jank
• Harald Haymerle
• Otto Doblhoff-Dier

Setting standards for information exchange in drug development

• Richard Lysakowski

Centrifugration and diagnostics

Centrifugation on the Web

• Richard Peters
• Robert S. Sikorski

People